FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...
Healthline17h
Americans Began Drinking More During the Pandemic, and They Haven’t Stopped
New research shows that heavy alcohol use among adults in the U.S. has persisted beyond the pandemic. In 2022, heavy alcohol ...